Financhill
Back

Aprea Therapeutics Stock Predictions

Aprea Therapeutics Stock Forecast

  • Is Aprea Therapeutics Stock Undervalued?
    The current Aprea Therapeutics [APRE] share price is $3.91. The Score for APRE is 4, which is 92% below its historic median score of 50, and infers higher risk than normal.
  • APRE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.

Will Aprea Therapeutics Stock Go Up Next Year?

Data Unavailable

Aprea Therapeutics Stock Rating

Data Unavailable

Aprea Therapeutics Stock Price History

Is APRE stock going to rise?

  • The current trend is moderately bullish and APRE is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
aprea.com

52-Week Data

52-Week High:
8.85
52-Week Low:
2.15

Prediction Charts

Market Cap:
21.24M
Price in USD:
3.91
Volume:
13.94K
Beta:
0.98

Technical Analysis

SMA50:
3.29
SMA100:
3.58
SMA200:
4.74
52-Wk Change:
16.37%

Stock Predictions

  • Is Aprea Therapeutics stock public?
    Yes, Aprea Therapeutics is a publicly traded company.
  • What is the Aprea Therapeutics stock quote today?
    The Aprea Therapeutics stock price is 3.91 USD today.
  • How to buy Aprea Therapeutics stock online?
    You can buy Aprea Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-11 2.66 2.60 2.77 2.15
Oct-14 2.62 2.56 2.62 2.51
Oct-15 2.60 3.05 3.20 2.58
Oct-16 4.32 3.50 4.39 3.21
Oct-18 5.01 4.40 5.01 4.15
Oct-21 4.40 4.30 4.54 4.27
Oct-22 4.35 4.18 4.35 4.00
Oct-23 4.18 3.90 4.18 3.86
Oct-24 3.90 3.90 4.20 3.87
Oct-25 4.05 4.08 4.15 4.05
Oct-28 3.99 4.28 4.28 3.99
Oct-29 4.17 4.25 4.30 4.03
Oct-30 4.34 4.01 4.42 3.92
Oct-31 3.86 3.91 4.17 3.82

Aprea Therapeutics Earnings

Data Unavailable

Aprea Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.57 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.54 per share, and an increase next year of $1.77 per share.

* Aprea Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.